Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 1/2007

01.01.2007 | Original Article

True smooth muscle neoplasms of the gastrointestinal tract: morphological spectrum and classification in a series of 85 cases from a single institute

verfasst von: Abbas Agaimy, Peter H. Wünsch

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Background and aim

True smooth-muscle neoplasms of the GI tract have been only rarely studied in the KIT era. Their incidence among other GI mesenchymal tumours and their clinicopathological spectrum have not been sufficiently analysed.

Materials and methods

We reviewed all GI mesenchymal lesions at the Pathology Institute of the Nuremberg Clinic Centre from 1994 through 2005.

Results

Among 262 lesions, there were 142 GISTs (54%) and 85 true smooth muscle neoplasms (32%). Smooth muscle neoplasms comprised 72 polypoid leiomyomas (78%, 5 oesophageal and 67 colorectal), 10 intramural leiomyomas (11%, 5 oesophageal, 4 gastric and one ileal), two intramural leiomyosarcomas in the sigmoid colon and ileum (2%) and one polypoid leiomyosarcoma involving the stomach, descending colon and the retroperitoneum concurrently. None of the leiomyomas with available follow-up have recurred or metastasised.

Conclusion

Smooth muscle neoplasms are the second most common mesenchymal neoplasms in the GI tract after GISTs. They may arise either from the muscularis mucosae or proper muscle layer forming polypoid and intramural lesions, respectively. Polypoid leiomyomas are more common in the rectosigmoid, while intramural ones mainly arise in the vicinity of the oesophagogastric junction. Polypoid leiomyomas are sufficiently treated by endoscopic resection, and local surgical excision is the treatment of choice for intramural leiomyomas. Intramural leiomyosarcomas are rare high-grade sarcomas that commonly have infiltrated into the surrounding tissue or metastasised by the time of diagnosis.
Literatur
1.
Zurück zum Zitat Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J (2000) Esophageal stromal tumors. A clinicopathologic, immunohistochemical and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol 24:211–222PubMedCrossRef Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J (2000) Esophageal stromal tumors. A clinicopathologic, immunohistochemical and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol 24:211–222PubMedCrossRef
2.
Zurück zum Zitat Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J (2000) Gastrointestinal stromal tumors and leiomyosarcomas in the colon. A clinicopathologic, immunohistochemical and molecular genetic study of 44 cases. Am J Surg Pathol 24:1339–1352PubMedCrossRef Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J (2000) Gastrointestinal stromal tumors and leiomyosarcomas in the colon. A clinicopathologic, immunohistochemical and molecular genetic study of 44 cases. Am J Surg Pathol 24:1339–1352PubMedCrossRef
3.
Zurück zum Zitat Miettinen M, Furlong M, Sarlomo-Rikala M, Burke A, Sobin LH, Lasota J (2001) Gastrointestinal stromal tumors, intramural leiomyomas and leiomyosarcomas in the rectum and anus. A clinicopathologic, immunohistochemical and molecular genetic study of 144 cases. Am J Surg Pathol 25:1121–1133PubMedCrossRef Miettinen M, Furlong M, Sarlomo-Rikala M, Burke A, Sobin LH, Lasota J (2001) Gastrointestinal stromal tumors, intramural leiomyomas and leiomyosarcomas in the rectum and anus. A clinicopathologic, immunohistochemical and molecular genetic study of 144 cases. Am J Surg Pathol 25:1121–1133PubMedCrossRef
4.
Zurück zum Zitat Miettinen M, Sarlomo-Rikala M, Sobin LH (2001) Mesenchymal tumors of the muscularis mucosae of the colon and rectum are benign leiomyomas that should be separated from gastrointestinal stromal tumors—a clinicopathologic and immunohistochemical study of eighty eight cases. Mod Pathol 14:950–956PubMedCrossRef Miettinen M, Sarlomo-Rikala M, Sobin LH (2001) Mesenchymal tumors of the muscularis mucosae of the colon and rectum are benign leiomyomas that should be separated from gastrointestinal stromal tumors—a clinicopathologic and immunohistochemical study of eighty eight cases. Mod Pathol 14:950–956PubMedCrossRef
5.
Zurück zum Zitat Miettinen M, Kopczynski J, Makhlouf HR et al (2003) Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 27:625–641PubMedCrossRef Miettinen M, Kopczynski J, Makhlouf HR et al (2003) Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 27:625–641PubMedCrossRef
6.
Zurück zum Zitat Fletcher CDM, Berman JJ, Corless C, Gorstein F, Lasota J, Longley B, Miettinen M, Oleary T, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33:459–465PubMedCrossRef Fletcher CDM, Berman JJ, Corless C, Gorstein F, Lasota J, Longley B, Miettinen M, Oleary T, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33:459–465PubMedCrossRef
7.
Zurück zum Zitat Sarlomo-Rikala M, El-Rifai W, Lahtinen T, Andersson LC, Miettinen M, Knuutila S (1998) Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas, and schwannomas. Hum Pathol 29:476–481PubMedCrossRef Sarlomo-Rikala M, El-Rifai W, Lahtinen T, Andersson LC, Miettinen M, Knuutila S (1998) Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas, and schwannomas. Hum Pathol 29:476–481PubMedCrossRef
8.
Zurück zum Zitat Paal E, Miettinen M (2001) Retroperitoneal leiomyomas. A clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas. Am J Surg Pathol 25:1355–1363PubMedCrossRef Paal E, Miettinen M (2001) Retroperitoneal leiomyomas. A clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas. Am J Surg Pathol 25:1355–1363PubMedCrossRef
9.
Zurück zum Zitat Farshid G, Pradhan M, Goldblum J, Weiss SW (2002) Leiomyosarcoma of somatic soft tissues. A tumor of vascular origin with multivariate analysis of outcome in 42 cases. Am J Surg Pathol 26:14–24PubMedCrossRef Farshid G, Pradhan M, Goldblum J, Weiss SW (2002) Leiomyosarcoma of somatic soft tissues. A tumor of vascular origin with multivariate analysis of outcome in 42 cases. Am J Surg Pathol 26:14–24PubMedCrossRef
10.
Zurück zum Zitat Agaimy A, Wünsch PH (2005) Sporadic Cajal cell hyperplasia is common in resection specimens for distal oesophageal carcinoma. A retrospective review of 77 consecutive surgical resection specimens. Virchows Arch 448:288–294PubMedCrossRef Agaimy A, Wünsch PH (2005) Sporadic Cajal cell hyperplasia is common in resection specimens for distal oesophageal carcinoma. A retrospective review of 77 consecutive surgical resection specimens. Virchows Arch 448:288–294PubMedCrossRef
12.
Zurück zum Zitat Miettinen M, Monihan J, Sarlomo-Rikala M, Kovatich AJ, Carr NJ, Emory TS, Sobin LH (1999) Gastrointestinal stromal tumors/smooth muscle tumors primary in the omentum and mesentery. Clinicopathologic and immunohistochemical study of cases. Am J Surg Pathol 23:1109–1118PubMedCrossRef Miettinen M, Monihan J, Sarlomo-Rikala M, Kovatich AJ, Carr NJ, Emory TS, Sobin LH (1999) Gastrointestinal stromal tumors/smooth muscle tumors primary in the omentum and mesentery. Clinicopathologic and immunohistochemical study of cases. Am J Surg Pathol 23:1109–1118PubMedCrossRef
13.
Zurück zum Zitat Yamaguchi U, Hasegawa T, Masuda T, Sekine S, Kawai A, Chuman H, Shimoda T (2004) Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis. Virchows Arch 445:142–150PubMedCrossRef Yamaguchi U, Hasegawa T, Masuda T, Sekine S, Kawai A, Chuman H, Shimoda T (2004) Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis. Virchows Arch 445:142–150PubMedCrossRef
14.
Zurück zum Zitat Miettinen M, Fetsch JF (2006) Evaluation of biological potential of smooth muscle tumours. Histopathology 48:97–105PubMedCrossRef Miettinen M, Fetsch JF (2006) Evaluation of biological potential of smooth muscle tumours. Histopathology 48:97–105PubMedCrossRef
15.
Zurück zum Zitat Fridie IL, Hong IS, Green WR (1992) Multicentric gastrointestinal and extragastrointestinal leiomyosarcomatosis: a case report. J Natl Med Assoc 84:629–631PubMed Fridie IL, Hong IS, Green WR (1992) Multicentric gastrointestinal and extragastrointestinal leiomyosarcomatosis: a case report. J Natl Med Assoc 84:629–631PubMed
16.
Zurück zum Zitat Zornig C, Thoma G, Schroder S (1990) Diffuse leiomyosarcomatosis of the colon. Cancer 65:570–572PubMedCrossRef Zornig C, Thoma G, Schroder S (1990) Diffuse leiomyosarcomatosis of the colon. Cancer 65:570–572PubMedCrossRef
17.
Zurück zum Zitat Roetman B, Schildhauer TA, Kuhnen C, Wardelmann E, Muhr G (2005) Polypoid pleomorphic sarcoma of the colon. Scand J Gastroenterol 40:1502–1506PubMedCrossRef Roetman B, Schildhauer TA, Kuhnen C, Wardelmann E, Muhr G (2005) Polypoid pleomorphic sarcoma of the colon. Scand J Gastroenterol 40:1502–1506PubMedCrossRef
18.
Zurück zum Zitat DeMeester TR, Skinner DB (1975) Polypoid sarcomas of the esophagus. A rare but potentially curable neoplasm. Ann Thorac Surg 20:405–417PubMedCrossRef DeMeester TR, Skinner DB (1975) Polypoid sarcomas of the esophagus. A rare but potentially curable neoplasm. Ann Thorac Surg 20:405–417PubMedCrossRef
19.
Zurück zum Zitat Miettinen M, Sobin LH, Lasota J (2005) Gastrointestinal stromal tumors of the stomach. A clinicopathologic, immunohistochemical and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29:52–68PubMedCrossRef Miettinen M, Sobin LH, Lasota J (2005) Gastrointestinal stromal tumors of the stomach. A clinicopathologic, immunohistochemical and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29:52–68PubMedCrossRef
20.
Zurück zum Zitat Medeiros F, Corless CL, Duensing A et al (2004) KIT-negative gastrointestinal stromal tumors. Proof of concept and therapeutic implications. Am J Surg Pathol 28:889–894PubMedCrossRef Medeiros F, Corless CL, Duensing A et al (2004) KIT-negative gastrointestinal stromal tumors. Proof of concept and therapeutic implications. Am J Surg Pathol 28:889–894PubMedCrossRef
21.
Zurück zum Zitat Goldsmith JD, Pawel B, Goldblum JR et al (2002) Detection and diagnostic utilization of placental alkaline phosphatase in muscular tissue and tumors with myogenic differentiation. Am J Surg Pathol 26:1627–1633PubMedCrossRef Goldsmith JD, Pawel B, Goldblum JR et al (2002) Detection and diagnostic utilization of placental alkaline phosphatase in muscular tissue and tumors with myogenic differentiation. Am J Surg Pathol 26:1627–1633PubMedCrossRef
22.
Zurück zum Zitat Miettinen M, Sarlomo-Rikala M, Kovatich AJ, Lasota J (1999) Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation. Mod Pathol 12:756–762PubMed Miettinen M, Sarlomo-Rikala M, Kovatich AJ, Lasota J (1999) Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation. Mod Pathol 12:756–762PubMed
Metadaten
Titel
True smooth muscle neoplasms of the gastrointestinal tract: morphological spectrum and classification in a series of 85 cases from a single institute
verfasst von
Abbas Agaimy
Peter H. Wünsch
Publikationsdatum
01.01.2007
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 1/2007
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-006-0092-y

Weitere Artikel der Ausgabe 1/2007

Langenbeck's Archives of Surgery 1/2007 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.